At least on the breakthroughs what you are looking for is the “Right to Try” movement, as well as various state healthcare regenerative medicine initiatives. You need to understand that we make discoveries of treatments all the time, but the reason you hear about incredible breakthroughs and then see nothing on the market for decades is that it takes enormous investments of time and money to get them to the point where they are approved to go to market.
Right to Try laws are either Federal or more often state level laws which allow patients to access treatments which have gone through some level of FDA approved clinical trials, but have not yet gone all the way to passing all required phases for market approval. One very broad Right to Try law can be found in Montana, which allows any patient with approval from their doctor to give informed consent and access any treatment which has passed phase I clinical trials.
One unfortunate flaw of Right to Try laws is that despite it being technically legal to access these treatments, it still requires manufacturer consent (you cant just rip of companies’ patents or anything), and most of these companies are pretty worried about the FDA retaliating against them if they were to make their drugs available under these state laws. There’s also various commercialization bans and other regulations limiting manufacturer activity. All of that comes together to make it hard if not impossible for manufacturers to actually provide access, so they don’t, so very little is available under these Right to Try laws. I’m personally looking at starting a fund to try to provide a sort of middleman for the process so companies can do this in a regulatorily compliant fashion, but it’s an uphill battle even when you can provide them technical guarantees, because there’s a real worry about retaliation down the line.
Another angle of “Healthcare YIMBYism” can be found in various state stem cell medicine laws, which often explicitly allow local physicians to perform treatments not approved by the FDA. Utah and Florida have both recently passed these (Florida’s is passed the house & senate but yet to be signed by governor). I actually just finished writing an article on these two laws and their differences which sadly got rejected by the publisher, but can send it to you if you want more information.
Lastly, there has been a lot of pushing by the Goldwater Institute recently for Right to Try for Individualized Treatments which allows patients to access treatments based on their personal genetic code (which by default are practically impossible to get through FDA clearance processes) which has been quite successful.
This doesn’t address all of your expense concerns of course, but at least on the breakthrough and getting technologies to market side of the equation, the movements you’re looking for do exist. Feel free to DM me if you’d like more information.
At least on the breakthroughs what you are looking for is the “Right to Try” movement, as well as various state healthcare regenerative medicine initiatives. You need to understand that we make discoveries of treatments all the time, but the reason you hear about incredible breakthroughs and then see nothing on the market for decades is that it takes enormous investments of time and money to get them to the point where they are approved to go to market.
Right to Try laws are either Federal or more often state level laws which allow patients to access treatments which have gone through some level of FDA approved clinical trials, but have not yet gone all the way to passing all required phases for market approval. One very broad Right to Try law can be found in Montana, which allows any patient with approval from their doctor to give informed consent and access any treatment which has passed phase I clinical trials.
One unfortunate flaw of Right to Try laws is that despite it being technically legal to access these treatments, it still requires manufacturer consent (you cant just rip of companies’ patents or anything), and most of these companies are pretty worried about the FDA retaliating against them if they were to make their drugs available under these state laws. There’s also various commercialization bans and other regulations limiting manufacturer activity. All of that comes together to make it hard if not impossible for manufacturers to actually provide access, so they don’t, so very little is available under these Right to Try laws. I’m personally looking at starting a fund to try to provide a sort of middleman for the process so companies can do this in a regulatorily compliant fashion, but it’s an uphill battle even when you can provide them technical guarantees, because there’s a real worry about retaliation down the line.
Another angle of “Healthcare YIMBYism” can be found in various state stem cell medicine laws, which often explicitly allow local physicians to perform treatments not approved by the FDA. Utah and Florida have both recently passed these (Florida’s is passed the house & senate but yet to be signed by governor). I actually just finished writing an article on these two laws and their differences which sadly got rejected by the publisher, but can send it to you if you want more information.
Lastly, there has been a lot of pushing by the Goldwater Institute recently for Right to Try for Individualized Treatments which allows patients to access treatments based on their personal genetic code (which by default are practically impossible to get through FDA clearance processes) which has been quite successful.
This doesn’t address all of your expense concerns of course, but at least on the breakthrough and getting technologies to market side of the equation, the movements you’re looking for do exist. Feel free to DM me if you’d like more information.